Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation

Journal of Investigative Dermatology

Volumn 133, Issue 10, 2013, Pages 2390-2399

  Hellberg, Lars ^a   Samavedam, Unni K S R L ^a   Holdorf, Karoline ^a   Hänsel, Martin ^a   Recke, Andreas ^a   Beckmann, Tina ^a   Steinhorst, Katja ^b   Boehncke, Wolf Henning ^b   Kirchner, Tina ^a   Möckel, Nicole ^a   Solbach, Werner ^a   Zillikens, Detlef ^a   Schmidt, Enno ^a   Ludwig, Ralf J ^a   Laskay, Tamás ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AUTOANTIBODY; METHYLPREDNISOLONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; BLISTER; DEGRANULATION; ENZYME PHOSPHORYLATION; EPIDERMOLYSIS BULLOSA ACQUISITA; EXOCYTOSIS; HUMAN; HUMAN TISSUE; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; INCUBATION TIME; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; PEMPHIGOID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY BURST; TISSUE INJURY;

EID: 84884291391     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.91     Document Type: Article

References (64)

1. Aga E, Katschinski DM, van ZG et al. (2002) Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 169: 898-905
2. Anhalt GJ, Bahn CF, Labib RS et al. (1981) Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J Clin Invest 68: 1097-101
3. Belgi G, Friedmann PS (2002) Traditional therapies: glucocorticoids, azathioprine, methotrexate, hydroxyurea. Clin Exp Dermatol 27: 546-54
4. Beutner EH, Rhodes EL, Holborow EJ (1967) Autoimmunity in chronic bullous skin diseases. Immunofluorescent demonstration of three types of antibodies to skin in sera of patients with pemphigus, bullous pemphigoid and in other human sera. Clin Exp Immunol 2: 141-51
5. Borrego L, Maynard B, Peterson EA et al. (1996) Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 148: 897-909
6. Buttgereit F, Brand MD, Muller M (1993) Effects of methylprednisolone on the energy metabolism of quiescent and ConA-stimulated thymocytes of the rat. Biosci Rep 13: 41-52
7. Cascao R, Rosario HS, Souto-Carneiro MM et al. (2010) Neutrophils in rheumatoid arthritis: more than simple final effectors. Autoimmun Rev 9: 531-5
8. Chen J, Tang H, Hay N et al. (2010) Akt isoforms differentially regulate neutrophil functions. Blood 115: 4237-46
9. Chiriac MT, Olaru F, Zillikens D et al. (2007a) Neutrophil-derived NADPH oxidase is required for antibody-induced tissue damage in experimental bullous pemphigoid. J Invest Derm 127:S69
10. Chiriac MT, Roesler J, Sindrilaru A et al. (2007b) NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 212: 56-65
11. Davies J, Sheppard K, Fletcher J (1984) Inhibition of human neutrophil secondary granule discharge by antiinflammatory agents. Inflammation 8: 343-51
12. Diaz LA, Ratrie H III, Saunders WS et al. (1990) Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest 86: 1088-94
13. Dubertret L, Bertaux B, Fosse M et al. (1980) Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol 103: 615-24
14. Faurschou M, Borregaard N (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 5: 1317-27
15. Gametchu B, Chen F, Sackey F et al. (1999) Plasma membrane-resident glucocorticoid receptors in rodent lymphoma and human leukemia models. Steroids 64: 107-19
16. Giudice GJ, Emery DJ, Diaz LA (1992) Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99: 243-50
17. Hirose M, Recke A, Beckmann T et al. (2011) Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice. J Immunol 187: 1176-83
18. Ignarro LJ (1971) Dissimilar effects of anti-inflammatory drugs on stability of lysosomes from peritoneal and circulating leukocytes and liver. Biochem Pharmacol 20: 2861-70
19. Iwata H, Kamio N, Aoyama Y et al. (2009) IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment. J Invest Dermatol 129: 919-26
20. Joly P, Roujeau JC, Benichou J et al. (2009) A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol 129: 1681-7
21. Joly P, Roujeau JC, Benichou J et al. (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346: 321-7
22. Jordon RE, Beutner EH, Witebsky E et al. (1967) Basement zone antibodies in bullous pemphigoid. JAMA 200: 751-6
23. Kaneko F, Minagawa T, Takiguchi Y et al. (1992) Role of cell-mediated immune reaction in blister formation of bullous pemphigoid. Dermatology 184: 34-9
24. Kassel O, Sancono A, Kratzschmar J et al. (2001) Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20: 7108-16
25. Konig H, Ponta H, Rahmsdorf HJ et al. (1992) Interference between pathwayspecific transcription factors: glucocorticoids antagonize phorbol esterinduced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 11: 2241-6
26. Labib RS, Anhalt GJ, Patel HP et al. (1986) Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136: 1231-5
27. Langan SM, Smeeth L, Hubbard R et al. (2008) Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 337:a180
28. Lasa M, Abraham SM, Boucheron C et al. (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22: 7802-11
29. Lasa M, Brook M, Saklatvala J et al. (2001) Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol 21: 771-80
30. Liu L, Wang YX, Zhou J et al. (2005) Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflamm Res 54: 37-41
31. Liu Z, Diaz LA, Troy JL et al. (1993) A passive transfer model of the organspecific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92: 2480-8
32. Liu Z, Giudice GJ, Zhou X et al. (1997) A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest 100: 1256-63
33. Liu Z, Shapiro SD, Zhou X et al. (2000) A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest 105: 113-23
34. Liu Z, Shipley JM, Vu TH et al. (1998) Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 188: 475-82
35. Ludwig RJ, Hardt K, Hatting M et al. (2009) Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin. Immunology 128: 196-205
36. Mandell GL, Rubin W, Hook EW (1970) The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity. J Clin Invest 49: 1381-8
37. Melgert BN, Olinga P, Van Der Laan JM et al. (2001) Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats. Hepatology 34: 719-28
38. Mizgerd JP, Kubo H, Kutkoski GJ et al. (1997) Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice. J Exp Med 186: 1357-64
39. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47
40. Nishie W, Sawamura D, Goto M et al. (2007) Humanization of autoantigen. Nat Med 13: 378-83
41. Nissen RM, Yamamoto KR (2000) The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14: 2314-29
42. Orchinik M, Murray TF, Moore FL(1991) A corticosteroid receptor in neuronal membranes. Science 252: 1848-51
43. Orciuolo E, Stanzani M, Canestraro M et al. (2007) Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis. J Leukoc Biol 82: 839-48
44. Pereira B, Bechara EJ, Mendonca JR et al. (1999) Superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs and skeletal muscles of rats treated with dexamethasone. Cell Biochem Funct 17: 15-9
45. Pereira B, Rosa LF, SafiDA et al. (1995) Hormonal regulation of superoxide dismutase, catalase, and glutathione peroxidase activities in rat macrophages. Biochem Pharmacol 50: 2093-8
46. Persellin RH, Ku LC (1974) Effects of steroid hormones on human polymorphonuclear leukocyte lysosomes. J Clin Invest 54: 919-25
47. Rider LG, Hirasawa N, Santini F et al. (1996) Activation of the mitogenactivated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J Immunol 157: 2374-80
48. Roujeau JC, Ingen-Housz-Oro S, Leroux C et al. (2009) Treatment of bullous pemphigoid and pemphigus. The French experience, 2009 update. G Ital Dermatol Venereol 144: 333-8
49. Sadowska AM, Klebe B, Germonpre P et al. (2007) Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication? Steroids 72: 1-6
50. Schleimer RP, Freeland HS, Peters SP et al. (1989) An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther 250: 598-605
51. Schmidt E, Obe K, Brocker EB et al. (2000a) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136: 174-8
52. Schmidt E, Reimer S, Kruse N et al. (2000b) Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin- 8 from cultured human keratinocytes. J Invest Dermatol 115: 842-8
53. Shimanovich I, Mihai S, Oostingh GJ et al. (2004) Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 204: 519-27
54. Sitaru C, Dahnrich C, Probst C et al. (2007) Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 16: 770-7
55. Sitaru C, Goebeler M, Zillikens D (2004) [Bullous autoimmune dermatoses (I): pathogenesis and diagnosis]. J Dtsch Dermatol Ges 2: 123-8
56. Sitaru C, Kromminga A, Hashimoto T et al. (2002a) Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 161: 301-11
57. Sitaru C, Mihai S, Otto C et al. (2005) Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 115: 870-8
58. Sitaru C, Schmidt E, Petermann S et al. (2002b) Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol 118: 664-71
59. Smith RJ (1977) Phagocytic release of lysosomal enzymes from guinea pig neutrophils-regulation by corticosteroids, autonomic neurohormones and cyclic nucleotides. Biochem Pharmacol 26: 2001-9
60. Stanley JR, Hawley-Nelson P, Yuspa SH et al. (1981) Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 24: 897-903
61. van Eeden SF, Klut ME, Walker BA et al. (1999) The use of flow cytometry to measure neutrophil function. J Immunol Methods 232: 23-43
62. Waldorf DS, Smith CW, Strauss AJ (1966) Immunofluorescent studies in pemphigus vulgaris. Confirmatory observations and evaluation of technical considerations. Arch Dermatol 93: 28-33
63. Yamamoto K, Inoue N, Masuda R et al. (2002) Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid. J Invest Dermatol 118: 485-92
64. Zillikens D (2009) Autoimmune bullous skin diseases. In: Burgdorf WHC, Plewig G, Wolff HH, Landthaler M (eds) Braun-Falco's Dermatology. Vol. 3rd. Springer: Heidelberg, 641-70